Skip to main content
. 2020 Oct 7;26(2):107–114. doi: 10.1002/onco.13534

Figure 2.

Figure 2

Odds ratio for female trial enrollment versus U.S. incidence or mortality. (A): Odds ratio (OR) with 95% confidence intervals for female trial enrollment compared with U.S. incidence by tumor type. “All cancers” includes all non–sex‐specific cancer types. Female to male ratios (female/male) for trial enrollment and US incidence, ORs, and p values are shown on the right. (B): OR for female trial enrollment compared with U.S. mortality by tumor type.